IP Library Granted Patent US 9,902,818
Granted Patent B2
US 9,902,818 · App. 14/704,047 · Granted Feb 27, 2018

Isolated and fixed micro and nano structures and methods thereof

Inventors: Joseph M. DeSimone (Chapel Hill, NC); Ginger Denison Rothrock (Durham, NC); Benjamin W. Maynor (Durham, NC); Jason P. Rolland (Belmont, MA)
Assignee: The University of North Carolina at Chapel Hill
C08J5/00A61K9/5138A61K9/5192B29C59/00B82Y10/00B82Y40/00G03F7/0002A61K9/0097A61K9/14C08J2335/02Y10T428/2982
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,902,818
App. No.
14/704,047
Granted
Feb 27, 2018
Kind
B2
Abstract

Discrete micro and nanoscale particles are formed in predetermined shapes and sizes and predetermined size dispersions. The particles can also be attached to a film to form arrays of particles on a film. The particles are formed from molding techniques that can include high throughput and continuous particle molding.

Claims (16)

1. A delivery device, comprising:

a dissolvable substrate of a first material, wherein the dissolvable substrate is dissolvable in biological fluids; and

a plurality of substantially monodisperse particles configured from a second material;

wherein, each particle of the plurality has (i) an engineered shape bounded by six substantially planar surfaces that each span respective entire sides of the particle and (ii) a maximum cross-sectional dimension of less than about 10 micrometers;

wherein the plurality of substantially monodisperse particles are coupled with the dissolvable substrate in a substantially predetermined orientation; and

wherein the second material comprises a therapeutically or pharmaceutically active agent dispersed throughout the entire particle.

2. The delivery device of claim 1 , wherein the maximum cross-sectional dimension is between about 5 nanometers and about 5 micrometers.

3. The delivery device of claim 1 , wherein the maximum cross-sectional dimension is less than about 500 nanometers.

4. The delivery device of claim 1 , wherein said delivery device has a modulus from about 0.1 MPa to about 500 MPa.

5. The delivery device of claim 1 , wherein the dissolvable substrate comprises a thickness of about twice a dimension of a particle of the plurality of particles.

6. The delivery device of claim 1 , further comprising a second plurality of particles of a second size coupled with the dissolvable substrate.

7. The delivery device of claim 1 , further comprising a second plurality of particles of a second shape coupled with the dissolvable substrate.

8. The delivery device of claim 1 , further comprising an agent configured to couple the plurality of substantially monodisperse particles with the dissolvable substrate by interactions selected from the group consisting of covalent bonding, ionic bonding, electrostatic binding, surface energy, hydrogen bonding, van der Waals forces, other intra- and inter-molecular forces, adhesives, and a magnetic force.

9. The delivery device of claim 1 , wherein said plurality of substantially monodisperse particles are arranged in a substantially ordered array.

10. The delivery device of claim 1 , wherein said dissolvable substrate is a sugar-based dissolvable film.

11. The delivery device of claim 10 , wherein said film is a sugar sheet comprising pullulan, hydroxypropylmethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, polyvinyl pyrrolidone, carboxymethyl cellulose, polyvinyl alcohol, sodium alginate, polyethylene glycol, xanthan gum, tragacanth gum, guar gum, acacia gum, arabic gum, polyacrylic acid, methylmethacrylate copolymer, carboxyvinyl polymer, amylose, high amylose starch, hydroxypropylated high amylose starch, dextrin, pectin, chitin, chitosan, levan, elsinan, collagen, gelatin, zein, gluten, soy protein isolate, whey protein isolate and/or casein, or combinations thereof.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 23, 2018
From: UNIVERSITY OF NORTH CAROLINA, CHAPEL HILL
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 045129/0230 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 7, 2017
From: DESIMONE, JOSEPH M.; ROTHROCK, GINGER DENISON; ROLLAND, JASON P.; MAYNOR, BENJAMIN W.
To: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Reel/Frame 043525/0350 →
Continuity (13)
Continuation 11594023 · Nov 7, 2006
Continuation In Part PCTUS2006023722 · Jun 19, 2006
Continuation In Part PCTUS2006034997 · Sep 7, 2006
Continuation In Part 10583570
Provisional Application 60734228 · Nov 7, 2005
Provisional Application 60762802 · Jan 27, 2006
Provisional Application 60799876 · May 12, 2006
Provisional Application 60691607 · Jun 17, 2005
Provisional Application 60714961 · Sep 7, 2005
Provisional Application 60531531 · Dec 19, 2003
Provisional Application 60583170 · Jun 25, 2004
Provisional Application 60604970 · Aug 27, 2004
Related Publication 20150307669A1 · Oct 29, 2015